Fenping Zheng Selected Research

Fenping Zheng Research Topics

Disease

7	Insulin Resistance 01/2023 - 01/2014
7	Obesity 01/2020 - 12/2012
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2014
4	Body Weight (Weight, Body) 01/2023 - 12/2012
4	Type 2 Diabetes Mellitus (MODY) 05/2016 - 02/2010
4	Hyperphagia (Overeating) 04/2016 - 12/2012
3	Non-alcoholic Fatty Liver Disease 01/2023 - 12/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 12/2015
2	Pseudohypoparathyroidism 04/2022 - 05/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Abdominal Obesity 01/2021 - 01/2014
2	Glucose Intolerance 10/2020 - 12/2012
2	Fatty Liver 01/2020 - 01/2017
2	Atherosclerosis 01/2017 - 01/2014
2	Hyperglycemia 12/2015 - 02/2011
1	Tetany (Spasmophilia) 04/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Intellectual Disability (Idiocy) 05/2020
1	Brachydactyly 05/2020
1	Hypocalcemia 05/2020
1	Hyperphosphatemia 05/2020
1	Neoplasms (Cancer) 01/2020
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2019
1	Laminopathies 12/2019
1	Micrognathism 12/2019
1	Alkalosis 01/2018
1	Hypokalemia 01/2018
1	Gitelman Syndrome 01/2018
1	Hypertension (High Blood Pressure) 05/2016
1	Albuminuria 05/2016
1	Anorexia 04/2016
1	Inflammation (Inflammations) 12/2015
1	Nephrogenic Diabetes Insipidus 07/2013
1	Hypercalcemia (Milk Alkali Syndrome) 07/2013
1	Syphilis 07/2013
1	Pyelonephritis 07/2013
1	Hyperinsulinism (Hyperinsulinemia) 06/2013
1	AIDS-Related Complex (ARC) 12/2012
1	Addison Disease (Addison's Disease) 06/2009

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 01/2023 - 06/2013
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2010
5	LipidsIBA 01/2023 - 12/2015
3	Dimenhydrinate (DMH)FDA LinkGeneric 04/2016 - 12/2012
2	Lamin Type A (Lamin A)IBA 01/2023 - 12/2019
2	Parathyroid Hormone (Parathormone)IBA 04/2022 - 05/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 10/2015
2	Prealbumin (Transthyretin)IBA 01/2021 - 04/2016
2	T0901317IBA 01/2017 - 01/2014
2	Liver X ReceptorsIBA 01/2017 - 01/2014
2	Uric Acid (Urate)IBA 05/2016 - 01/2014
2	Neuropeptide YIBA 04/2016 - 06/2013
2	LeptinIBA 06/2013 - 12/2012
1	fibroblast growth factor 21IBA 01/2023
1	CanagliflozinIBA 01/2023
1	SodiumIBA 01/2023
1	Calcium Gluconate (CBG)IBA 04/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	AutoantibodiesIBA 01/2022
1	Insulin-Like PeptidesIBA 05/2021
1	Circular RNAIBA 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2021
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 10/2020
1	Hormones (Hormone)IBA 05/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2020
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2020
1	AcidsIBA 01/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020
1	Acyl-CoA OxidaseIBA 01/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Peroxisomal Bifunctional EnzymeIBA 01/2020
1	Member 3 Solute Carrier Family 12IBA 01/2018
1	AdipokinesIBA 01/2017
1	CholesterolIBA 05/2016
1	Nonesterified Fatty Acids (NEFA)IBA 05/2016
1	Triglycerides (Triacylglycerol)IBA 05/2016
1	Appetite Depressants (Anorectics)IBA 04/2016
1	Lipid PeroxidesIBA 12/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2015
1	EnzymesIBA 12/2015
1	Gliclazide (Diamicron)IBA 10/2015
1	Insulin Glargine (Lantus)FDA Link 10/2015
1	lipoxin A4IBA 01/2015
1	AdiponectinIBA 01/2014
1	LithiumIBA 07/2013
1	Vasopressins (Vasopressin)IBA 07/2013
1	ElectrolytesIBA 07/2013
1	ReaginsIBA 07/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2009
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2009

Therapy/Procedure

1	Intraperitoneal Injections 01/2020
1	Radiotherapy 01/2020
1	Therapeutics 10/2015